Bausch Health Companies | VRX - Net Income



Bausch Health Companies reported $148M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Amgen USD 1.43B 298M Jun/2025
ANI Pharmaceuticals USD 8.14M 7.54M Jun/2025
Aurora Cannabis CAD -15210000 46.88M Jun/2025
Bausch Health Companies USD 148M 206M Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Canopy Growth CAD -41530000 80.37M Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Danaher USD 555M 399M Jun/2025
Drreddys Laboratories INR 14.18B 45M Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
Novo Nordisk 26.5B 2.53B Jun/2025
Pacira USD -4847000 9.66M Jun/2025
Perrigo USD -8400000 2M Jun/2025
Prestige Brands USD 61.78M 11.65M Jun/2025
Supernus Pharmaceuticals USD 22.5M 34.33M Jun/2025
Vertex Pharmaceuticals USD 1.03B 386.6M Jun/2025
Zoetis USD 718M 87M Jun/2025